QuidelOrtho Corp. Stock
€39.20
Your prediction
QuidelOrtho Corp. Stock
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
Cons
Performance of QuidelOrtho Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
QuidelOrtho Corp. | -0.510% | -2.475% | 7.065% | -50.365% | -41.905% | -59.018% | - |
Boston Scientific | 0.000% | 0.730% | 8.661% | 39.001% | 34.137% | 102.703% | 107.114% |
Waters Corp. | -0.030% | 0.491% | 18.452% | 32.016% | 8.411% | 27.891% | 75.814% |
Illumina Inc. | -1.150% | -0.409% | -7.295% | -46.102% | -20.482% | -67.827% | -63.403% |
Comments
News
QuidelOrtho Opens New Distribution Center in Pedricktown, NJ
QuidelOrtho Corporation (Nasdaq: QDEL) has launched a second state-of-the-art United States distribution center in Pedricktown, New Jersey. This strategic endeavor epitomizes QuidelOrtho’s
QuidelOrtho Reports First Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and